** Animal health shares cap 2025 with solid gains from vaccines and pet meds demand, as IDEXX IDXX.O and Elanco ELAN.N leads the charge for a rebound from 2024 losses and Zoetis ZTS.N ends the year in negative territory
** IDXX and ELAN are up 65% and 87%, respectively, this year, driven by robust demand for their vaccines, medicines and diagnostic tools
** Unlike peers IDEXX and Elanco, Zoetis stock has plunged 22% this year on subdued sales, profit shortfalls and concerns around inventory normalization; ZTS is set for a second consecutive year of losses
** Wall Street coverage tilts bullish per LSEG data, with 'buy'/'strong buy' rating dominating for ELAN, ZTS and IDXX as analysts expect strong 2026 outlooks for their offerings
Animal health stocks performance in 2025 https://reut.rs/3YlR8Zd
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))